Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang +3 more
wiley +1 more source
Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy. [PDF]
Buddle S +27 more
europepmc +1 more source
Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology
Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen +8 more
wiley +1 more source
Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in <i>Epm2b</i>-Deficient Mice. [PDF]
Zafra-Puerta L +6 more
europepmc +1 more source
Tropism and Retinal Transduction Efficiency of Adeno-Associated Virus Serotypes in Mice. [PDF]
Wu W, McRae J, Brown A, Agbaga MP.
europepmc +1 more source
Reply to a letter from Miesbach and Srivastava: response to hemophilia B gene therapy based on adeno-associated virus serotype 5 antibody status. [PDF]
Klamroth R, Monahan PE, Le Quellec S.
europepmc +1 more source
Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery. [PDF]
Tripathi S +5 more
europepmc +1 more source
Heterogeneity in an adeno-associated virus transfection-based production process limits the production efficiency. [PDF]
Ladd B +5 more
europepmc +1 more source
Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
In this review, we examined the progression of genome manipulation from stochastic nuclease‐mediated cutting toward precise editing and programmable genome writing. We discussed tools like multi‐kilobase RNA‐guided integrators and Artificial Intelligence (AI)‐designed effectors and showed how these advances enable researchers to treat genomes as ...
Kerui Huang +19 more
wiley +1 more source

